Bansisons Tea Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2026 ,inter alia, to consider and approve Reduction in Capital
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novyra Pharmachem Limited (formerly Bansisons Tea Industries Limited) has scheduled a Board meeting for May 16, 2026 to consider a proposal for Capital Reduction under Sections 66 and other applicable provisions of the Companies Act, 2013. The meeting will also address routine matters including fixing the Annual General Meeting date, book closure dates, appointment of scrutinizer, and approval of Director's Report for FY2026. The company operates from Surat, Gujarat with CIN L21001GJ1987PLC171085 and is listed on BSE with scrip code 519353. The specific details of the capital reduction (whether it involves cash return to shareholders, share consolidation, or loss elimination) are not disclosed in this pre-meeting notice.
Capital reduction can signal various corporate actions including return of excess capital to shareholders or restructuring of share capital. Until the meeting outcome is known, shareholders should monitor for further announcements specifying the exact nature and mechanism of the reduction.